{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T16:10:29Z","timestamp":1780071029705,"version":"3.54.0"},"reference-count":51,"publisher":"BMJ","issue":"5","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Case Rep"],"accepted":{"date-parts":[[2026,4,13]]},"published-print":{"date-parts":[[2026,5]]},"abstract":"<jats:p>The decision to resume anticoagulation after intracerebral haemorrhage is a major clinical challenge, with current evidence offering limited guidance on balancing thrombotic and haemorrhagic risks. We present a case that highlights the intersection of multiple rare but clinically significant conditions against a background of prothrombotic risk. The patient\u2019s course exemplifies the complex interplay between thrombosis and bleeding and the therapeutic dilemmas surrounding the timing and choice of anticoagulation. Current evidence, derived largely from observational cohorts and small randomised trials, supports a reduction in ischaemic events with anticoagulation but consistently demonstrates increased haemorrhagic risk, with limited advice on how best to individualise decisions. This case underscores the importance of multidisciplinary management, shared decision-making and the pressing need for personalised strategies in navigating anticoagulation after intracerebral haemorrhage.<\/jats:p>","DOI":"10.1136\/bcr-2025-271302","type":"journal-article","created":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T15:55:26Z","timestamp":1780070126000},"page":"e271302","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":0,"title":["Anticoagulation after intracerebral haemorrhage: individualised management in a complex prothrombotic setting"],"prefix":"10.1136","volume":"19","author":[{"given":"Onur","family":"Tanglay","sequence":"first","affiliation":[{"name":"Department of Neurology and Neurophysiology, Liverpool Hospital, Sydney, NSW, Australia"},{"name":"School of Clinical Medicine, Faculty of Medicine and Health, University of New South Wales, Sydney, NSW, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dennis","family":"Cordato","sequence":"additional","affiliation":[{"name":"Department of Neurology and Neurophysiology, Liverpool Hospital, Sydney, NSW, Australia"},{"name":"School of Clinical Medicine, Faculty of Medicine and Health, University of New South Wales, Sydney, NSW, Australia"},{"name":"Ingham Institute for Applied Medical Research, Sydney, NSW, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Ng","sequence":"additional","affiliation":[{"name":"School of Clinical Medicine, Faculty of Medicine and Health, University of New South Wales, Sydney, NSW, Australia"},{"name":"Department of Haematology, Liverpool Hospital, Sydney, NSW, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danny","family":"Hsu","sequence":"additional","affiliation":[{"name":"School of Clinical Medicine, Faculty of Medicine and Health, University of New South Wales, Sydney, NSW, Australia"},{"name":"Department of Haematology, Liverpool Hospital, Sydney, NSW, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zinta","family":"Harrington","sequence":"additional","affiliation":[{"name":"School of Clinical Medicine, Faculty of Medicine and Health, University of New South Wales, Sydney, NSW, Australia"},{"name":"Department of Respiratory and Sleep Medicine, Liverpool Hospital, Sydney, NSW, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cecilia","family":"Cappelen-Smith","sequence":"additional","affiliation":[{"name":"Department of Neurology and Neurophysiology, Liverpool Hospital, Sydney, NSW, Australia"},{"name":"School of Clinical Medicine, Faculty of Medicine and Health, University of New South Wales, Sydney, NSW, Australia"},{"name":"Ingham Institute for Applied Medical Research, Sydney, NSW, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2026,5,29]]},"reference":[{"key":"2026052908552045000_19.5.e271302.1","doi-asserted-by":"publisher","DOI":"10.1161\/circresaha.121.319949"},{"key":"2026052908552045000_19.5.e271302.2","doi-asserted-by":"publisher","DOI":"10.1002\/ana.24652"},{"key":"2026052908552045000_19.5.e271302.3","doi-asserted-by":"crossref","DOI":"10.3390\/jcm13195930","article-title":"Treatment-Related Reversible Cerebral Vasoconstriction Syndrome","volume":"13","author":"Avola","year":"2024","journal-title":"J Clin Med"},{"key":"2026052908552045000_19.5.e271302.4","doi-asserted-by":"crossref","DOI":"10.1186\/s12929-022-00857-4","article-title":"Pathophysiology of reversible cerebral vasoconstriction syndrome","volume":"29","author":"Chen","year":"2022","journal-title":"J Biomed Sci"},{"key":"2026052908552045000_19.5.e271302.5","doi-asserted-by":"publisher","DOI":"10.1007\/s10067-013-2434-9"},{"key":"2026052908552045000_19.5.e271302.6","doi-asserted-by":"crossref","DOI":"10.1016\/j.ensci.2021.100351","article-title":"A case of reversible cerebral vasoconstriction syndrome associated with anti-phospholipid antibody syndrome and systemic lupus erythematosus","volume":"24","author":"Shima","year":"2021","journal-title":"eNeurologicalSci"},{"key":"2026052908552045000_19.5.e271302.7","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1177\/23969873241296803","article-title":"Oral Anticoagulation following intracranial haemorrhage in patients with atrial fibrillation","volume":"10","author":"Shoamanesh","year":"2025","journal-title":"Eur Stroke J"},{"key":"2026052908552045000_19.5.e271302.8","doi-asserted-by":"crossref","first-page":"S19","DOI":"10.31128\/AJGP-09-23-6970","article-title":"Anticoagulation in the context of post-intracerebral haemorrhage: A narrative review","volume":"53","author":"Tran","year":"2024","journal-title":"Aust J Gen Pract"},{"key":"2026052908552045000_19.5.e271302.9","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1016\/j.jtha.2023.10.020","article-title":"Between a rock and a hard place: resumption of oral anticoagulant therapy after intracranial hemorrhage","volume":"22","author":"Grainger","year":"2024","journal-title":"J Thromb Haemost"},{"key":"2026052908552045000_19.5.e271302.10","doi-asserted-by":"crossref","DOI":"10.1007\/s11940-017-0477-y","article-title":"Resumption of Anticoagulation After Intracranial Hemorrhage","volume":"19","author":"da Silva","year":"2017","journal-title":"Curr Treat Options Neurol"},{"key":"2026052908552045000_19.5.e271302.11","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.115.015735"},{"key":"2026052908552045000_19.5.e271302.12","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2015.0846"},{"key":"2026052908552045000_19.5.e271302.13","doi-asserted-by":"publisher","DOI":"10.1002\/ana.25079"},{"key":"2026052908552045000_19.5.e271302.14","doi-asserted-by":"publisher","DOI":"10.1161\/STROKEAHA.116.016327"},{"key":"2026052908552045000_19.5.e271302.15","doi-asserted-by":"crossref","first-page":"3035","DOI":"10.1161\/STROKEAHA.122.038752","article-title":"Effectiveness and Safety of Antithrombotic Medication in Patients With Atrial Fibrillation and Intracranial Hemorrhage: Systematic Review and Meta-Analysis","volume":"53","author":"Ivany","year":"2022","journal-title":"Stroke"},{"key":"2026052908552045000_19.5.e271302.16","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1016\/j.thromres.2013.10.024","article-title":"Effect of warfarin on intracranial hemorrhage incidence and fatal outcomes","volume":"132","author":"Witt","year":"2013","journal-title":"Thromb Res"},{"key":"2026052908552045000_19.5.e271302.17","unstructured":"Shoamanesh A , Sharma M , Dowlatshahi D , et al . Non-vitamin k oral anticoagulants in intracerebral hemorrhage survivors with atrial fibrillation: primary results of the naspaf-ich randomized trial. International Stroke Conference Los Angeles, CA, 2020"},{"key":"2026052908552045000_19.5.e271302.18","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(21)00298-2"},{"key":"2026052908552045000_19.5.e271302.19","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(21)00264-7"},{"key":"2026052908552045000_19.5.e271302.20","article-title":"Antithrombotic treatment after stroke due to intracerebral haemorrhage","volume":"1","author":"Cochrane","year":"2023","journal-title":"Cochrane Database Syst Rev"},{"key":"2026052908552045000_19.5.e271302.21","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.1056\/NEJMoa2012883","article-title":"Low-Dose Edoxaban in Very Elderly Patients with Atrial Fibrillation","volume":"383","author":"Okumura","year":"2020","journal-title":"N Engl J Med"},{"key":"2026052908552045000_19.5.e271302.22","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1016\/S0140-6736(25)00333-2","article-title":"Direct oral anticoagulants versus no anticoagulation for the prevention of stroke in survivors of intracerebral haemorrhage with atrial fibrillation (PRESTIGE-AF): a multicentre, open-label, randomised, phase 3 trial","volume":"405","author":"Veltkamp","year":"2025","journal-title":"The Lancet"},{"key":"2026052908552045000_19.5.e271302.23","doi-asserted-by":"publisher","DOI":"10.1161\/STROKEAHA.110.593087"},{"key":"2026052908552045000_19.5.e271302.24","doi-asserted-by":"publisher","DOI":"10.1111\/j.1538-7836.2010.03882.x"},{"key":"2026052908552045000_19.5.e271302.25","doi-asserted-by":"publisher","DOI":"10.1093\/icvts\/ivs545"},{"key":"2026052908552045000_19.5.e271302.26","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehy056"},{"key":"2026052908552045000_19.5.e271302.27","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2019-215213"},{"key":"2026052908552045000_19.5.e271302.28","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1111\/bjh.19635","article-title":"Guidelines on the investigation and management of antiphospholipid syndrome","volume":"205","author":"Arachchillage","year":"2024","journal-title":"Br J Haematol"},{"key":"2026052908552045000_19.5.e271302.29","doi-asserted-by":"publisher","DOI":"10.1111\/jth.14935"},{"key":"2026052908552045000_19.5.e271302.30","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2018-04-848333"},{"key":"2026052908552045000_19.5.e271302.31","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2022.10.008"},{"key":"2026052908552045000_19.5.e271302.32","doi-asserted-by":"publisher","DOI":"10.7326\/M19-0291"},{"key":"2026052908552045000_19.5.e271302.33","doi-asserted-by":"crossref","first-page":"e426","DOI":"10.1016\/S2352-3026(16)30079-5","article-title":"Rivaroxaban versus warfarin to treat patients with thrombotic antiphospholipid syndrome, with or without systemic lupus erythematosus (RAPS): a randomised, controlled, open-label, phase 2\/3, non-inferiority trial","volume":"3","author":"Cohen","year":"2016","journal-title":"Lancet Haematol"},{"key":"2026052908552045000_19.5.e271302.34","first-page":"1571","article-title":"16th International Congress on Antiphospholipid Antibodies Task Force Report on Antiphospholipid Syndrome Treatment Trends","volume":"29","author":"Cohen","year":"2020","journal-title":"Lupus (Los Angel)"},{"key":"2026052908552045000_19.5.e271302.35","first-page":"e977","article-title":"2026 AHA\/ACC\/ACCP\/ACEP\/CHEST\/SCAI\/SHM\/SIR\/SVM\/SVN Guideline for the Evaluation and Management of Acute Pulmonary Embolism in Adults: A Report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines","volume":"153","author":"Creager","year":"2026","journal-title":"Circulation"},{"key":"2026052908552045000_19.5.e271302.36","doi-asserted-by":"publisher","DOI":"10.1111\/j.1538-7836.2010.04129.x"},{"key":"2026052908552045000_19.5.e271302.37","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0169055","article-title":"Familial Clustering of Venous Thromboembolism \u2013 A Danish Nationwide Cohort Study","volume":"11","author":"Sindet-Pedersen","year":"2016","journal-title":"PLoS ONE"},{"key":"2026052908552045000_19.5.e271302.38","doi-asserted-by":"publisher","DOI":"10.1001\/archinternmed.2008.589"},{"key":"2026052908552045000_19.5.e271302.39","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.1093\/aje\/kwy004","article-title":"Hyperhomocysteinemia and Risk of First Venous Thrombosis: The Influence of (Unmeasured) Confounding Factors","volume":"187","author":"Ospina-Romero","year":"2018","journal-title":"Am J Epidemiol"},{"key":"2026052908552045000_19.5.e271302.40","doi-asserted-by":"crossref","DOI":"10.1002\/rth2.12739","article-title":"A call to action: MTHFR polymorphisms should not be a part of inherited thrombophilia testing","volume":"6","author":"Deloughery","year":"2022","journal-title":"Research and Practice in Thrombosis and Haemostasis"},{"key":"2026052908552045000_19.5.e271302.41","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1207541"},{"key":"2026052908552045000_19.5.e271302.42","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1016\/S0140-6736(24)02842-3","article-title":"Extended treatment of venous thromboembolism with reduced-dose versus full-dose direct oral anticoagulants in patients at high risk of recurrence: a non-inferiority, multicentre, randomised, open-label, blinded endpoint trial","volume":"405","author":"Couturaud","year":"2025","journal-title":"The Lancet"},{"key":"2026052908552045000_19.5.e271302.43","doi-asserted-by":"crossref","first-page":"3625","DOI":"10.1016\/j.jtha.2025.07.034","article-title":"Low-dose direct oral anticoagulants for secondary prevention in patients at high risk for recurrence due to history of recurrent venous thromboembolic events or severe thrombophilia: a retrospective analysis of the Italian Survey on anTicoagulated pAtients RegisTry 2","volume":"23","author":"Poli","year":"2025","journal-title":"J Thromb Haemost"},{"key":"2026052908552045000_19.5.e271302.44","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1177\/1076029617729214","article-title":"Protocol Modification of Apixaban for the Secondary Prevention of Thrombosis Among Patients With Antiphospholipid Syndrome Study","volume":"24","author":"Woller","year":"2018","journal-title":"Clin Appl Thromb Hemost"},{"key":"2026052908552045000_19.5.e271302.45","doi-asserted-by":"publisher","DOI":"10.1177\/1076029615615960"},{"key":"2026052908552045000_19.5.e271302.46","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2021005808"},{"key":"2026052908552045000_19.5.e271302.47","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp-2016-314697"},{"key":"2026052908552045000_19.5.e271302.48","doi-asserted-by":"crossref","first-page":"2317","DOI":"10.1212\/WNL.0000000000004704","article-title":"Brain microbleeds, anticoagulation, and hemorrhage risk: Meta-analysis in stroke patients with AF","volume":"89","author":"Charidimou","year":"2017","journal-title":"Neurology (ECronicon)"},{"key":"2026052908552045000_19.5.e271302.49","doi-asserted-by":"crossref","first-page":"1698","DOI":"10.1093\/eurheartj\/ehab141","article-title":"Serial assessment of biomarkers and the risk of stroke or systemic embolism and bleeding in patients with atrial fibrillation in the ENGAGE AF-TIMI 48 trial","volume":"42","author":"Oyama","year":"2021","journal-title":"Eur Heart J"},{"key":"2026052908552045000_19.5.e271302.50","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.thromres.2022.07.013","article-title":"Optimal management, prevalence, and clinical behavior of saddle pulmonary embolism: A systematic review and meta-analysis","volume":"217","author":"Ata","year":"2022","journal-title":"Thromb Res"},{"key":"2026052908552045000_19.5.e271302.51","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2313040"}],"container-title":["BMJ Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bcr-2025-271302","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T15:55:30Z","timestamp":1780070130000},"score":1,"resource":{"primary":{"URL":"https:\/\/casereports.bmj.com\/lookup\/doi\/10.1136\/bcr-2025-271302"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":51,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2026,5,29]]},"published-print":{"date-parts":[[2026,5]]}},"alternative-id":["10.1136\/bcr-2025-271302"],"URL":"https:\/\/doi.org\/10.1136\/bcr-2025-271302","relation":{},"ISSN":["1757-790X"],"issn-type":[{"value":"1757-790X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5]]}}}